Germany

Sartorius acquires majority stake in CellGenix

05-Jul-2021 By Rachel Arthur

Sartorius is strengthening its product portfolio for cell and gene therapies with the acquisition of a majority stake in German reagent manufacturer CellGenix.

AstraZeneca in deal with Germany’s IDT Biologika to boost vaccine manufacturing capability

11-Feb-2021 By Jane Byrne

AstraZeneca and IDT Biologika are exploring options to accelerate output of finished COVID-19 Vaccine AstraZeneca in the second quarter of 2021 in order to help support Europe’s immediate vaccination needs during the pandemic.

WuXi Biologics acquires first EU drug product facility through Bayer deal

16-Jan-2020 By Ben Hargreaves

WuXi Biologics will add Bayer’s Leverkusen drug product facility, as part of its continued expansion into the European market.

Germany seen as the leader of European pharma industry

31-Oct-2019 By Ben Hargreaves

Research ranks Germany as the leading nation within Europe due to the high rating of its finished production manufacturing and potential for growth.

Merz completes construction of new plant and filling line

17-Sep-2019 By Ben Hargreaves

Merz announces that it has completed the construction of a new plant for its botulinum neurotoxin product and unveils a ‘robot-controlled’ filling line.

Wacker Chemie turns to biopharma during period of uncertainty

12-Jul-2019 By Ben Hargreaves

Wacker Biotech looks to corner the microbial expression system niche, as Wacker Chemie’s traditional areas of focus face difficult market conditions.

Rexgenero extends European reach with expanded manufacturing

29-May-2019 By Maggie Lynch

Partnership with German Red Cross will see Rexgenero’s lead drug candidate reaching broader patient base in clinical trials.